NCT02446652 2025-05-29Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical CancerNational Institute of CancerologíaPhase 3 Withdrawn
NCT06149767 2023-11-29Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical CancerFujian Cancer HospitalPhase 2 Not yet recruiting26 enrolled